GPT and metabolic syndrome: Although the present study showed that there was no significant difference in the prevalence of fatty liver with ALT elevation, hypertension, dyslipidemia, or IGT between light drinkers and non-drinkers, the prevalence of those undergoing treatment for dyslipidemia or IGT was significantly higher in non-drinkers than light drinkers.